Spironolactone Tablet
Product Images NDC 71205-772

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71205-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure of spironolactone, depicted as a labeled molecular diagram showing its steroidal framework and functional groups including ketones, a lactone ring, and a thioacetate moiety.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A Kaplan-Meier survival curve chart comparing probability over time in months for Spironolactone and Placebo groups. The solid line represents Spironolactone with 822 subjects, and the dashed line represents Placebo with 841 subjects. The chart includes a log-rank p-value of less than 0.001 indicating statistical significance.*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone with placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot shows HR values with markers and confidence intervals aligned horizontally against a reference line indicating no effect.*
FDA Label Image

71205-772-30 (Spironolactone 04)

71205-772-30 (Spironolactone 04)
Label for Spironolactone 25 mg oral tablets, packaged by Proficient Rx LP. The label indicates a bottle of 30 tablets, each containing 25 mg Spironolactone USP. Tablets are described as white, round, unscored, debossed with 'MP 35'. Manufacturer is Frontida BioPharm, Inc., Philadelphia, PA. Storage instructions specify 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.